ETView Medical, Ltd. Announces US FDA Clearance of a 510(k) Pre-marketing Notification Application Expanding the VivaSight(TM)-DL line of Innovative Airway Devices
The VivaSight product family provides continuous airway visualization during thoracic surgical procedures requiring lung isolation
TEL AVIV, Israel--(Healthcare Sales & Marketing Network)--ETView (ETVW.TA) today announced that the company has received ...
Devices, FDA
ETView Medical, VivaSight-DL, Airway Management System
Devices, FDA
ETView Medical, VivaSight-DL, Airway Management System
Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical Trial for Perceval (TM) S Sutureless Aortic Valve in the United States
Primary objective of the prospective, non randomized trial is to demonstrate the safety and effectiveness of the PERCEVAL S sutureless valve in support of receiving FDA PMA clearance
MILAN, Italy--(Healthcare Sales & Marketing Network)--Sorin Group, (Re...
Devices, Cardiology, FDA
Sorin Group, PERCEVAL S, sutureless aortic valve, aortic valve
Devices, Cardiology, FDA
Sorin Group, PERCEVAL S, sutureless aortic valve, aortic valve
ProUroCare Announces Changes to Management and Board of Directors
MINNEAPOLIS--(Healthcare Sales & Marketing Network)--ProUroCare Medical Inc. (PUMD) is pleased to announce the appointment of Stan Myrum as Interim CEO of the company and as a Director on its Board of Directors. Stan has over 30 years of medical device exp...
Devices, Urology, Personnel
ProUroCare, ProUroScan
Devices, Urology, Personnel
ProUroCare, ProUroScan
Vascular Solutions Announces Re-Launch of Venture(R) Catheter
Catheter previously offered by St. Jude Medical is once again available
Venture catheter provides precision guidewire placement in complex interventions, with over seven years of clinical use
Available in rapid-exchange, over-the-wire, and coronary s...
Devices, Interventional, Product Launch
Vascular Solutions, Venture catheter
Devices, Interventional, Product Launch
Vascular Solutions, Venture catheter
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
GAITHERSBURG, Md., April 29, 2013 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Sigma-Tau Pharmaceuticals, Inc. today announced that Dave Lemus has been promoted to the newly created position of Chief Executive Officer, effective i...
Biopharmaceuticals, Personnel
Sigma-Tau Pharmaceuticals
Biopharmaceuticals, Personnel
Sigma-Tau Pharmaceuticals
Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., April 29, 2013 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the debut of the next generation of the Camino(R) platform, an advanced monitoring system for continuous intracra...
Devices, Neurosurgery, Monitoring, Product Launch
Integra LifeSciences, Camino, ICP, ICP monitoring, intracranial pressure
Devices, Neurosurgery, Monitoring, Product Launch
Integra LifeSciences, Camino, ICP, ICP monitoring, intracranial pressure
Integra LifeSciences Launches Integra(R) Compact Cranial Closure System
Features Product at American Association of Neurological Surgeons (AANS) Annual Meeting
PLAINSBORO, N.J., April 29, 2013 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the launch of the Inte...
Devices, Neurosurgery, Product Launch
Integra LifeSciences, Compact Cranial Closure System
Devices, Neurosurgery, Product Launch
Integra LifeSciences, Compact Cranial Closure System
KCI Announces Global Rollout of Novel Skin Graft Harvesting Tool
US Wound Care Physicians Introduced to CelluTome Epidermal Harvesting System
SAN ANTONIO--(Healthcare Sales & Marketing Network)--Kinetic Concepts, Inc. today announced that its CelluTome Epidermal Harvesting System will be showcased at a company-spo...
Devices, Wound Care, Product Launch
Kinetic Concepts, CelluTome, Epidermal Harvesting System
Devices, Wound Care, Product Launch
Kinetic Concepts, CelluTome, Epidermal Harvesting System
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd. (TEVA) today announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer. Mr. Sekhri has over...
Biopharmaceuticals, Personnel
Teva Pharmaceutical
Biopharmaceuticals, Personnel
Teva Pharmaceutical
Spine Wave Announces U.S. FDA's 510K Clearance of the StaXx(R) IB System, an Intervertebral Body Fusion Device
The StaXx(R) IB System Expands the StaXx(R) Product Portfolio and Offers the Advantage of an Expandable Intervertebral Body Fusion Device With Bone Graft Chambers
SHELTON, CT--(Healthcare Sales & Marketing Network) - Spine Wave, Inc. a privately held me...
Devices, Orthopaedic, Neurosurgery, FDA
Spine Wave, StaXx IB System, PEEK spacers, spine surgery
Devices, Orthopaedic, Neurosurgery, FDA
Spine Wave, StaXx IB System, PEEK spacers, spine surgery
Merck and Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
WHITEHOUSE STATION, N.J. & NEW YORK--(Healthcare Sales & Marketing Network)--Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada (Merck), and Pfizer Inc. (PFE) today announced that they have entered into a worldwide (except Japan) ...
Biopharmaceuticals, Endocrinology
Merck, Pfizer, ertugliflozin, diabetes
Biopharmaceuticals, Endocrinology
Merck, Pfizer, ertugliflozin, diabetes
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
CARMIEL, Israel, April 29, 2013 -- (Healthcare Sales & Marketing Network) -- Protalix BioTherapeutics, Inc. (PLX.TA) (PLX.TA), announced today that the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS) and the Public Health Ins...
Biopharmaceuticals, Regulatory
Protalix BioTherapeutics, UPLYSO, alfataliglicerase, Gaucher disease
Biopharmaceuticals, Regulatory
Protalix BioTherapeutics, UPLYSO, alfataliglicerase, Gaucher disease
Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System(R)
The ARROW® VPS G4 Device provides accurate and precise PICC placement
LIMERICK, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, announces that it...
Devices, FDA
Teleflex, ARROW VPS G4, PICC
Devices, FDA
Teleflex, ARROW VPS G4, PICC
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
RALEIGH, N.C., April 29, 2013 -- (Healthcare Sales & Marketing Network) -- BioDelivery Sciences International, Inc. (BDSI) announced the appointment of Thomas W. D'Alonzo to the company's Board of Directors. Mr. D'Alonzo previously served on the BDSI Boa...
Biopharmaceuticals, Personnel
BioDelivery Sciences International, BUNAVAIL
Biopharmaceuticals, Personnel
BioDelivery Sciences International, BUNAVAIL
Bayer to acquire Conceptus, Inc.
Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio
WAYNE, N.J. and MOUNTAIN VIEW, Calif., April 29, 2013 -- (Healthcare Sales & Marketing Network) -- Bayer intends to broaden its portfolio in the ...
Biopharmaceuticals, Mergers & Acquisitions
Bayer HealthCare Pharmaceuticals, Conceptus, Essure procedure, birth control
Biopharmaceuticals, Mergers & Acquisitions
Bayer HealthCare Pharmaceuticals, Conceptus, Essure procedure, birth control
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Recommended as Treatment for Advanced Basal Cell Carcinoma
Curis Eligible for $6 Million Milestone on European Commission Approval
LEXINGTON, Mass., April 26, 2013 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (CRIS), an oncology-focused c...
Biopharmaceuticals, Oncology, Regulatory
Curis , Basal Cell Carcinoma, Erivedge, vismodegib
Biopharmaceuticals, Oncology, Regulatory
Curis , Basal Cell Carcinoma, Erivedge, vismodegib
NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
First Volumetric OCT Device Cleared for Endoscopic Imaging Now Also Cleared for Esophageal Imaging Indication
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for...
Devices, FDA
NinePoint Medical, NvisionVLE, coherence tomography, endoscopic imaging
Devices, FDA
NinePoint Medical, NvisionVLE, coherence tomography, endoscopic imaging
Ketchikan Medical Center Implements The SurgiCount Safety-Sponge(R) System
First hospital in the planned system-wide implementation across all PeaceHealth facilities
IRVINE, Calif., April 26, 2013 -- (Healthcare Sales & Marketing Network) -- SurgiCount Medical, Inc., the wholly-owned operating subsidiary of Patient Safety Tec...
Devices, Surgery
SurgiCount Medical, Patient Safety Technologies, Safety-Sponge
Devices, Surgery
SurgiCount Medical, Patient Safety Technologies, Safety-Sponge
Sectra Signs Distribution Agreement in Puerto Rico
International medical imaging IT company, Sectra (SECT-B.ST) announces an exclusive agreement with Answer Medical Solutions to distribute its healthcare IT suite throughout Puerto Rico. The agreement includes Sectra's RIS/PACS, radiation dose monitoring s...
Devices, Radiology, Distribution
Sectra North America, Answer Medical Solutions, RIS/PACS
Devices, Radiology, Distribution
Sectra North America, Answer Medical Solutions, RIS/PACS
Retrophin Names Horacio Plotkin, M.D. as Chief Medical Officer
Brings wealth of clinical research and regulatory submission expertise to help advance pipeline
NEW YORK--(Healthcare Sales & Marketing Network)--Retrophin, Inc. (RTRX), a pharmaceutical company focused on the discovery and development of drugs for the ...
Biopharmaceuticals, Personnel
Retrophin
Biopharmaceuticals, Personnel
Retrophin

